Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Sulfur – selenium or tellurium compound
Patent
1994-12-30
1996-10-29
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Sulfur, selenium or tellurium compound
514724, 514923, A61K 3110, A61K 31045
Patent
active
055696791
ABSTRACT:
A method of pharmaceutically managing snoring is provided by the instillation intranasally of a solution containing 1-20% methylsulfonylmethane by weight dissolved in water so as to saturate the nasal mucous membranes. Preferably, the solution has between 10%-16% by weight methysulfonylmethane. The solution may be buffered, and/or a mild analgesic may be included. The method prefers that instillation occur as close to the sleep event as possible, and it should be at least within one hour before a person retires for sleep. The solution may be introduced by spray or drop-wise, and a product packaging the solution in a suitable container is described.
REFERENCES:
patent: 4477469 (1984-10-01), Herschler
patent: 4863748 (1989-09-01), Herschler
"Y Snore Anti-Snoring Nose Drops" Product, Manufactured By Datong Health Care, China.
Martin Timothy J.
Rollins John W.
Russell A. Krueger Pharmaceuticals, Inc.
LandOfFree
Pharmacologic management of snoring does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmacologic management of snoring, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmacologic management of snoring will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1785947